Mustang Bio Inc (MBIO)
0.2283
-0.01
(-3.14%)
USD |
NASDAQ |
Nov 15, 16:00
0.212
-0.02
(-7.14%)
After-Hours: 20:00
Mustang Bio Total Assets (Quarterly): 7.193M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.193M |
| June 30, 2024 | 8.519M |
| March 31, 2024 | 14.59M |
| December 31, 2023 | 17.74M |
| September 30, 2023 | 20.57M |
| June 30, 2023 | 29.09M |
| March 31, 2023 | 73.61M |
| December 31, 2022 | 92.42M |
| September 30, 2022 | 108.84M |
| June 30, 2022 | 121.90M |
| March 31, 2022 | 136.96M |
| December 31, 2021 | 125.17M |
| September 30, 2021 | 134.71M |
| June 30, 2021 | 143.21M |
| March 31, 2021 | 141.82M |
| December 31, 2020 | 109.90M |
| September 30, 2020 | 86.07M |
| Date | Value |
|---|---|
| June 30, 2020 | 96.83M |
| March 31, 2020 | 68.56M |
| December 31, 2019 | 73.44M |
| September 30, 2019 | 83.84M |
| June 30, 2019 | 92.62M |
| March 31, 2019 | 50.48M |
| December 31, 2018 | 42.75M |
| September 30, 2018 | 49.51M |
| June 30, 2018 | 55.68M |
| March 31, 2018 | 61.09M |
| December 31, 2017 | 63.49M |
| September 30, 2017 | 67.88M |
| June 30, 2017 | 73.84M |
| March 31, 2017 | 75.02M |
| December 31, 2016 | 27.50M |
| September 30, 2016 | 11.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.193M
Minimum
Sep 2024
143.21M
Maximum
Jun 2021
80.56M
Average
89.24M
Median
Total Assets (Quarterly) Benchmarks
| Fortress Biotech Inc | 145.68M |
| AIM ImmunoTech Inc | 15.72M |
| Perspective Therapeutics Inc | 385.92M |
| Protalix BioTherapeutics Inc | 91.54M |
| Armata Pharmaceuticals Inc | 108.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.85M |
| Shareholders Equity (Quarterly) | -8.656M |